MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20249048

October 16, 2024

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.2%(0.4ml:0.8mg,按C₂₁H₂₃NO₃计)

化学药品

October 16, 2024

Company Information

Applicant Company

湖北省武汉市经济技术开发区高新技术工业园28号

Manufacturing Company

湖北省武汉市经济技术开发区高新技术工业园28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath